Targeting CD38 with Daratumumab Plus Chemotherapy for Patients with Advanced-Stage Plasmablastoid Large B-Cell Lymphoma

Ryu, Y. K., Ricker, E. C., Soderquist, C. R., Francescone, M. A., Lipsky, A. H., & Amengual, J. E. (2022). Targeting CD38 with Daratumumab Plus Chemotherapy for Patients with Advanced-Stage Plasmablastoid Large B-Cell Lymphoma. Journal of Clinical Medicine, 11(16), 4928. https://doi.org/10.3390/jcm11164928
Authors:
Yun Kyoung Ryu
Edd C. Ricker
Craig R. Soderquist
Mark A. Francescone
Andrew Lipsky
Jennifer E. Amengual
Affiliated Authors:
Yun Kyoung Ryu
Edd C. Ricker
Craig R. Soderquist
Mark A. Francescone
Andrew Lipsky
Jennifer E. Amengual
Columbia Affiliation:
Subjects:
Viral-Related Cancers in Immunocompromised Patients (OpenAlex Topic)
Role of Fibroblast Activation in Cancer Progression (OpenAlex Topic)
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
Author Keywords:
plasmablastoid
lymphoma
daratumumab
anti-cd38
elink
Publication Type:
Article
Unique ID:
10.3390/jcm11164928
PMID:
36013165
DOI:
10.3390/jcm11164928
Journal:
Journal of Clinical Medicine
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: